Clinical Trials List
Protocol NumberL00070 IN 305 B0
2009-08-01 - 2011-06-30
Phase III
Terminated2
-
Trial Applicant
Orient EuroPharma Co., Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/19
Investigators and Locations
Co-Principal Investigator
- 何景良 Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- 張平穎 Division of Hematology & Oncology
- Tsu-Yi Chao Division of Hematology & Oncology
- 戴明燊 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Hsien-Kun Chang Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
764 participants
